학술논문
Upadacitinib versus placebo or adalimumab with background methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate: A subgroup analysis of a phase III randomized controlled trial in Central and Eastern European patients
Document Type
Article
Author
Source
In: Drugs in Context . (Drugs in Context, 19 October 2020, 9)
Subject
Language
English
ISSN
17404398
17451981
17451981